Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-22T14:05:44.167Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic malignant syndrome and carbamazepine?

Published online by Cambridge University Press:  02 January 2018

Therese van Amelsvoort
Therese van Amelsvoort*
Affiliation:
Centre Hospitalier de Luxembourg 4, rue Barbie L-1210, Luxembourg
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 164 , Issue 2 , February 1994 , pp. 269 - 270
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

References

Macdonald, R. L. (1989) Carbamazepine: mechanisms of action. In Antiepileptic Drugs (3rd edn) (eds Levy, R., Mattson, R., Meldrum, B., et al), pp. 447–455. New York: Raven Press.Google Scholar
O'Griofa, F. M. & Voris, J. C. (1991) Neuroleptic malignant syndrome associated with carbamazepine. Southern Medical Journal, 84, 1378–1380.10.1097/00007611-199111000-00023Google Scholar
Schmutz, M. (1992) Antiepileptics and the hippocampus. In The Temporal Lobes and the Limbic System (eds Trimble, M. R. & Bolwig, T. G., pp. 91–99). Wrightson Biomedical Publishing.Google Scholar
Weller, M. & Kornhuber, J. (1992) Pathophysiologie und Therapie des malignen neuroleptischen Syndroms. Nervenarzt, 63, 645–655.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.